Statement of comprehensive income - the Novozymes Group


Audited by PwC
Note 2009 2008
            DKK million  DKK million  
Net profit 1,194  1,062 
13 Fair value adjustment of Novo Nordisk stock  - (15)
13 - transfered to Financial income/costs (29) (38)
Currency translation of subsidiaries and minority interests 84  48 
Hedges of net investments in foreign subsidiaries  - (14)
Tax related to hedges of net investments in foreign subsidiaries
Cash flow hedges 195  18 
- transfered to Financial income/costs (75) (62)
Tax related to cash flow hedges    
Other comprehensive income 185  (54)
Comprehensive income for the year, total   1,379  1,008   
Attributable to:
Shareholders in the parent company 1,380  1,007 
Minority interests   (1)  
1,379  1,008 
My Report